エピソード

  • Final Episode
    2022/12/20

    This week, I have an announcement to make.

    Find out more at
    https://LifeScienceTodayPodcast.com


    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    5 分
  • Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago
    2022/11/30

    Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Sanofi/Takeda
    UniQure & CSL
    Fog Pharma
    Merck + Imago

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    9 分
  • Indivior + Opiant, Regeneron + CytomX, Rezo, Provention
    2022/11/22

    A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Indivior + Opiant
    Regeneron + CytomX
    Rezo
    Provention

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    6 分
  • Intellia, Regeneron, Viatris + Oyster Point
    2022/11/16

    More CRISPR data, oncology wins, and a new player in ophthalmology

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Intellia
    Regeneron
    Viatris + Oyster Point

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    10 分
  • Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye
    2022/11/02

    Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Sumitovant + Myovant
    Thermo Fisher + Binding Site Group
    Astellas & Taysha
    Agios
    Vaxctye

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    9 分
  • FDA, AbbVie + DJS, Roche + Hookipa, Kyverna
    2022/10/26

    Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future.

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    FDA
    AbbVie + DJS
    Roche + Hookipa
    Kyverna

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    8 分
  • DICE, Odyssey, Fred Hutch, Merck (MSD)
    2022/10/18

    One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news


    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    DICE
    Odyssey
    Fred Hutch
    Merck (MSD), Merck Story 2

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    7 分
  • Nested, Cellarity, Replimune, Estrella
    2022/10/11

    Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Nested Therapeutics
    Cellarity
    Replimune
    Estrella Biopharma

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示
    7 分